2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$72.41-$2.72 (-3.63%)
Price as of Oct 02, 2026 6:13 PM EDT- $3.7BMarket Cap
- 52.02%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$72.41-$2.72 (-3.63%)
CELC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $75.13 | ||
Change | -$4.39 (-5.52%) | ||
Open | $78.38 | ||
High | $79.18 | ||
Low | $75.00 | ||
Previous Close | $79.52 | ||
Volume | 1,096,887 | ||
30-Day Average Volume | 979,712 | ||
1-Week Change | -5.34% | ||
1-Month Change | -18.32% | ||
1-Year Change | 52.02% | ||
3-Year Change | 721.99% | ||
5-Year Change | 323.98% | ||
Fundamentals | |||
Shares Outstanding | 48.9M | ||
Total Assets | $828.2M | ||
Market Cap | $3.7B | ||
Enterprise Value | $4.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$55.5M | ||
EBIT | $300,000.00 | ||
EBITDA | $359,000.00 | ||
Net Working Capital | $689.0M | ||
EPS | -$1.44 | ||
Enterprise Value/EBITDA | 11,831 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -52 | ||
PEG | 1 | ||
Price/Free Cash Flow | -66 | ||
Price/Operating Cash Flow | -66 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue